Journal of Cardiac Failure最新文献

{"title":"Equip, Engage, Empower: Considerations for Effective Values Elicitation in the Population With LVAD","authors":"REBECCA S. STEINBERG MD, MSc , RASHONDA A. CARLISLE MD , CATHERINE SHELTON RN , SHELLEY A. HALL MD , ADITI NAYAK MD, MS","doi":"10.1016/j.cardfail.2025.06.007","DOIUrl":"10.1016/j.cardfail.2025.06.007","url":null,"abstract":"","PeriodicalId":15204,"journal":{"name":"Journal of Cardiac Failure","volume":"31 9","pages":"Pages 1405-1407"},"PeriodicalIF":8.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144567478","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Knowledge of Illness Trajectory and Symptoms of Heart Failure in Patients with Acute Coronary Syndrome","authors":"MOMOKO MASUDA PT ,&nbsp;KAZUKI TOBITA PT ,&nbsp;AYUMI GODA MD ,&nbsp;DAISUKE FUJISAWA MD ,&nbsp;SHINSUKE TAKEUCHI MD ,&nbsp;KOHEI KOYAMA MD ,&nbsp;SYOICHI TASHIRO MD ,&nbsp;SHIN YAMADA MD ,&nbsp;KYOKO SOEJIMA MD ,&nbsp;TAKASHI KOHNO MD","doi":"10.1016/j.cardfail.2024.11.013","DOIUrl":"10.1016/j.cardfail.2024.11.013","url":null,"abstract":"<div><h3>Background</h3><div>Preventive management of heart failure (HF) should involve strategies to increase awareness of HF in patients with pre-HF and those at risk of HF. However, the perception of HF in patients with acute coronary syndrome<span> (ACS) remains unclear. This study aimed to assess patient understanding of the definition of HF for the public—that is, its illness trajectory (intermittent decline), impact on life expectancy (HF would limit life expectancy), and symptoms (shortness of breath, swelling)—that was introduced by the Japanese Circulation Society.</span></div></div><div><h3>Methods</h3><div>This cross-sectional, questionnaire-based study enrolled 209 emergently admitted patients with ACS who underwent a cardiac rehabilitation program at a single university-based hospital. We identified the clinical characteristics of patients who understood HF definition.</div></div><div><h3>Results</h3><div>Among the enrolled patients (median age, 69 years; males, 81.3%; 59.8% with ST-elevation myocardial infarction), 64.0% and 53.1% chose the correct answers regarding HF illness trajectory and impact on life expectancy, respectively. While 92.3% of the patients correctly chose shortness of breath as an HF symptom, 56.7% correctly chose swelling. Patient understanding of the definition of HF was associated with younger age, but not with HF risk (i.e., hypertension, diabetes, higher natriuretic peptide levels, lower left ventricular ejection fraction) and history of symptomatic HF.</div></div><div><h3>Conclusions</h3><div>Among patients with ACS who participated in the cardiac rehabilitation program in this cohort, patient understanding of HF definition was suboptimal. Effective measures to improve their understanding should be considered to enhance the prevention of HF.</div></div>","PeriodicalId":15204,"journal":{"name":"Journal of Cardiac Failure","volume":"31 9","pages":"Pages 1430-1439"},"PeriodicalIF":8.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142836503","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Value of Community in Heart Failure","authors":"Anuradha Lala MD ,&nbsp;Robert J. Mentz MD","doi":"10.1016/j.cardfail.2025.08.003","DOIUrl":"10.1016/j.cardfail.2025.08.003","url":null,"abstract":"","PeriodicalId":15204,"journal":{"name":"Journal of Cardiac Failure","volume":"31 9","pages":"Pages 1377-1378"},"PeriodicalIF":8.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145020931","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"An Evaluation of the Heart Failure Somatic Perception Scale Using Item Response Theory","authors":"QUIN E. DENFELD PhD, RN, FAHA, FAAN, FHFSA ,&nbsp;CORRINE Y. JURGENS PhD, RN, FAHA, FAAN, FHFSA ,&nbsp;SHIRIN O. HIATT MPh, MS, RN ,&nbsp;NATHAN F. DIECKMANN PhD ,&nbsp;MARY ROBERTS DAVIS PhD, RN ,&nbsp;S. ALBERT CAMACHO MD ,&nbsp;CHRISTOPHER V. CHIEN MD, FACC ,&nbsp;CHRISTOPHER S. LEE PhD, RN, FAHA, FAAN, FHFSA","doi":"10.1016/j.cardfail.2025.04.011","DOIUrl":"10.1016/j.cardfail.2025.04.011","url":null,"abstract":"","PeriodicalId":15204,"journal":{"name":"Journal of Cardiac Failure","volume":"31 9","pages":"Pages 1486-1489"},"PeriodicalIF":8.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144018793","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Dietary Inflammatory Score and Incident Heart Failure in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study","authors":"CHRISTINE M. PARK MD ,&nbsp;LAUREN BALKAN MD ,&nbsp;JOANNA B. RINGEL MPH ,&nbsp;JAMES SHIKANY PhD ,&nbsp;ROBIN BOSTICK MD, MPH ,&nbsp;SUZANNE E. JUDD MD ,&nbsp;CHANEL JONAS MD ,&nbsp;PANKAJ ARORA MD ,&nbsp;TODD M. BROWN MD, MSPH ,&nbsp;RAEGAN DURANT MD, MPH ,&nbsp;SCOTT HUMMEL MD, MS ,&nbsp;ELIZABETH A. JACKSON MD ,&nbsp;MADELINE R. STERLING MD, MPH ,&nbsp;RYAN DEMMER PhD, MPH ,&nbsp;MELANA YUZEFPOLSKAYA MD ,&nbsp;EMILY B. LEVITAN ScD. ,&nbsp;MONIKA M. SAFFORD MD ,&nbsp;PARAG GOYAL MD, MSc","doi":"10.1016/j.cardfail.2024.12.009","DOIUrl":"10.1016/j.cardfail.2024.12.009","url":null,"abstract":"<div><h3>Background</h3><div>Inflammation plays a key role in the development of heart failure (HF), and diet is a known modifiable factor that modulates systemic inflammation. The dietary inflammatory score (DIS) is a tool that quantifies the inflammatory components of diet. We sought to determine whether the DIS is associated with incident HF events.</div></div><div><h3>Methods</h3><div><span>We examined a total of 17,975 participants without HF at baseline who were in the REasons for Geographic and Racial Differences in Stroke (REGARDS) cohort. The main exposure variable was the DIS quartile, which was derived from the Food Frequency Questionnaire<span> obtained at baseline study enrollment. The main outcome was an incident HF event, defined as hospitalization due to HF or death. To examine the association between the DIS and incident HF events, we conducted Cox proportional hazard regression modeling, adjusting for total </span></span>energy intake, sociodemographic factors and pro-inflammatory lifestyle behaviors.</div></div><div><h3>Results</h3><div><span>The sample mean age was 64 + 9.2 years, 55.8% were female, and 32.3% were Black. Over a median follow-up of 11.1 years, we observed 900 incident HF events, including 752 hospitalizations and 148 deaths due to HF. In an adjusted model, the highest DIS quartile (Q4) was associated with incident HF (HR 1.26 95% CI 1.03–1.54). Of note, these findings remained, even after adjusting for comorbid conditions and physiological parameters. In an age-stratified analysis, the association was present only in those aged &lt; 65 years (Q4: HR 1.65 95% CI 1.08–2.51). Moreover, the association was present for heart failure with reserved ejection fraction (Q4: HR 1.44 95% CI 1.07–1.94) but not for </span>heart failure with preserved ejection fraction.</div></div><div><h3>Conclusion</h3><div>The highest DIS quartile was associated with incident HF events. These findings indicate the potential value of specific dietary patterns to prevent HF.</div></div>","PeriodicalId":15204,"journal":{"name":"Journal of Cardiac Failure","volume":"31 9","pages":"Pages 1440-1449"},"PeriodicalIF":8.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143005801","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Underpinnings of Heart Failure With Preserved Ejection Fraction in Women - From Prevention to Improving Function. A Co-publication With the American Journal of Preventive Cardiology and the Journal of Cardiac Failure","authors":"ANKITHA RADAKRISHNAN ,&nbsp;SALONI AGRAWAL ,&nbsp;NAUSHEEN SINGH ,&nbsp;ANNA BARBIERI ,&nbsp;LESLEE J. SHAW ,&nbsp;MARTHA GULATI ,&nbsp;ANURADHA LALA","doi":"10.1016/j.cardfail.2025.01.008","DOIUrl":"10.1016/j.cardfail.2025.01.008","url":null,"abstract":"<div><div>Heart failure with preserved ejection fraction (HFpEF) represents a major clinical challenge with rising global prevalence. Women have a nearly double lifetime risk of developing HFpEF compared to heart failure with reduced ejection fraction (HFrEF). In HFpEF, sex differences emerge both in how traditional cardiovascular risk factors (such as hypertension, obesity, and diabetes) affect cardiac function and through distinct pathophysiological mechanisms triggered by sex-specific events like menopause and adverse pregnancy outcomes. These patterns influence not only disease development, but also therapeutic responses, necessitating sex-specific approaches to treatment. This review aims to synthesize existing knowledge regarding HFpEF in women including traditional and sex-specific risk factors, pathophysiology, presentation, and therapies, while outlining important knowledge gaps that warrant further investigation. The impact of HFpEF spans a woman's entire lifespan, requiring prevention and management strategies tailored to different life stages. While understanding of sex-based differences in HFpEF has improved, significant knowledge gaps persist. Through examination of current evidence and challenges, this review highlights promising opportunities for innovative research, therapeutic development, and clinical care approaches that could transform the management of HFpEF in women.</div></div>","PeriodicalId":15204,"journal":{"name":"Journal of Cardiac Failure","volume":"31 9","pages":"Pages 1460-1475"},"PeriodicalIF":8.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143458132","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Facilitators and Barriers to Values Discussions Following LVAD Implantation: Perspectives from Diverse Patients and Family Caregivers","authors":"AVERY C. BECHTHOLD PhD, BSN, RN ,&nbsp;DEBORAH B. EJEM PhD ,&nbsp;COLLEEN K. MCILVENNAN PhD, DNP, ANP ,&nbsp;DANIEL D. MATLOCK MD, MPH ,&nbsp;CHRISTOPHER E. KNOEPKE PhD, MSW ,&nbsp;JESSE LEJEUNE CRNP ,&nbsp;MARIE A. BAKITAS DNSc, NP-C, FAAN ,&nbsp;J. NICHOLAS ODOM PhD, RN","doi":"10.1016/j.cardfail.2024.11.015","DOIUrl":"10.1016/j.cardfail.2024.11.015","url":null,"abstract":"<div><h3>Background</h3><div>Delivering care that is responsive to who or what is most important to patients and family caregivers is a key aspect of quality care, yet it remains unclear how clinicians can best support individuals in expressing their personal values. We aimed to describe patient- and family caregiver–identified facilitators and barriers to engaging in values discussions with clinicians following implantation of a left ventricular assist device (LVAD).</div></div><div><h3>Methods and results</h3><div>Using a qualitative descriptive approach, patients with an LVAD and their caregivers participated in 1-on-1 semistructured interviews and self-reported sociodemographics (January 2023–July 2023). Qualitative data were analyzed using thematic analysis and descriptive statistics were computed for quantitative data.</div></div><div><h3>Results</h3><div>Patients (n = 27; ages 30–76 years) were predominantly male (59%) and non-Hispanic Black (67%). Caregivers (n = 21; ages 27–76) were female (76%), non-Hispanic Black (67%), and a spouse/partner (62%). Facilitators (5 shared across patient/caregiver groups; 8 unique across patient/caregiver groups) included a perceived close relationship (patient/caregiver), values alignment (patient/caregiver), clinician discussion initiation (patient/caregiver), facing an impending decision (patient/caregiver), 1-on-1 dyadic interactions (patient/caregiver), being assertive (patient), positive dyadic communication (caregiver), and involvement of a third party (caregiver). Barriers (2 shared; 7 unique) included belief that their values are already known (patient/caregiver), sensitivity about values (patient/caregiver), uncertainty about timing (patient), poor clinical communication (patient), patient hopelessness (patient), perceived lack of clinician time (caregiver), and having a reserved personality (caregiver).</div></div><div><h3>Conclusion</h3><div>Findings offer insight into actionable facilitators and barriers to discussions promoting incorporation of patient and family values into LVAD maintenance and chronic disease management.</div></div>","PeriodicalId":15204,"journal":{"name":"Journal of Cardiac Failure","volume":"31 9","pages":"Pages 1393-1404"},"PeriodicalIF":8.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142872336","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Hospital-Level Variation and Predictive Model for Diagnosis of Transthyretin Amyloid Cardiomyopathy Among Patients Hospitalized Due to Heart Failure","authors":"SATOSHI SHOJI MD, PhD ,&nbsp;NICOLE SOLOMON PhD ,&nbsp;KAREN CHISWELL PhD ,&nbsp;SENTHIL SELVARAJ MD, MS, MA ,&nbsp;MICHEL G. KHOURI MD ,&nbsp;SABRA C. LEWSEY MD, MPH ,&nbsp;LORI BAYLOR PhD ,&nbsp;MARIANNA BRUNO PharmD, MPH ,&nbsp;GREGG C. FONAROW MD ,&nbsp;STEPHEN J. GREENE MD","doi":"10.1016/j.cardfail.2025.03.013","DOIUrl":"10.1016/j.cardfail.2025.03.013","url":null,"abstract":"","PeriodicalId":15204,"journal":{"name":"Journal of Cardiac Failure","volume":"31 9","pages":"Pages 1480-1485"},"PeriodicalIF":8.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143752859","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Real-World Survival Outcomes With Cardiac Contractility Modulation: Methodological Validation Using Cardiac Resynchronization Therapy Data","authors":"ANDREW J. SAUER MD ,&nbsp;RYAN HASS ,&nbsp;GARY CRANKE ,&nbsp;DANIEL BURKHOFF MD ,&nbsp;ISHU RAO MD","doi":"10.1016/j.cardfail.2025.04.013","DOIUrl":"10.1016/j.cardfail.2025.04.013","url":null,"abstract":"","PeriodicalId":15204,"journal":{"name":"Journal of Cardiac Failure","volume":"31 9","pages":"Pages 1490-1492"},"PeriodicalIF":8.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144142707","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Revisiting Myocardial Recovery in Anthracycline Cardiomyopathy: Defining the Steps to Success in Contemporary Practice","authors":"MICHAEL C. HILL M.D., M.S., ,&nbsp;JOSHUA A. JACOBS Pharm.D., Ph.D. ,&nbsp;JANE E. WILCOX M.D., M.Sc.","doi":"10.1016/j.cardfail.2025.07.003","DOIUrl":"10.1016/j.cardfail.2025.07.003","url":null,"abstract":"","PeriodicalId":15204,"journal":{"name":"Journal of Cardiac Failure","volume":"31 9","pages":"Pages 1390-1392"},"PeriodicalIF":8.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144707631","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}